InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: hyperopia post# 605603

Friday, 06/30/2023 7:18:36 AM

Friday, June 30, 2023 7:18:36 AM

Post# of 704075

The final product is tested for identity, purity, potency, and stability against pre-established release criteria for the product. And then as I just said, there are a number of additional tests (sterility, endotoxin, mycoplasma) to ensure that the product contains no contaminants. All of this testing takes about a month or more.



Hyperopia,
Thanks for the clarification. I didn’t know that. You are correct (and I was wrong) that they are using fresh, not frozen leukapheresis material.
Yesterday I asked LL if it's possible to manufacture an autologous dendritic cell vaccine (DCVax-L) by using cryopreserved apheresis material.
Here is LL’s reply:

June 29, 2023

Hi xxxxx,

It is potentially possible, but the viability and potency of the dendritic cells may not be as good as when they are fresh.

LL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News